Brief: Evaxion Biotech Q2 Basic EPS USD -0.12
14/08/2024 12:00
Aug 14 (Reuters) - Evaxion Biotech Q2 net income USD -6.198 million. * Q2 pretax profit USD -6.198 million * Q2 operating income USD -4.581 million
Recent news on Evaxion A/S
See all newsEvaxion A/S reports results for the quarter ended June 30 - Earnings Summary
Denmark's Evaxion Q2 net loss narrows on lower expenses
Brief: Evaxion Q2 Basic EPS USD -0.01
Evaxion A/S expected to post a loss of 31 cents a share - Earnings Preview
Brief: Evaxion A/S - Expands Pipeline Of Cancer Vaccine Programs With Evx-05 Against Brain Cancer Glioblastoma